Return
Editorial Comment
DOI:10.1097/JU.0000000000002182.02.png)
Abstract
En
Keywords:
GEMCITABINE PLUS CISPLATIN
PHASE-III TRIAL
NEOADJUVANT CHEMOTHERAPY
BLADDER
METHOTREXATE
VINBLASTINE
CANCER
DOXORUBICIN
CYSTECTOMY
SURVIVAL
Journal
IF:
6.8
Papers:
6.6W
Citations:
4.2W
Organization
Cited Papers
No cited papers available

